H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection

by Chang, C.-C, Chang, Y.-S, Chen, J.-H, Chen, L.-F, Chen, W.-S, Hsu, H.-C, Hu, L.-F, Kuo, P.-I, Liang, Y.-C, Lin, S.-H, Lin, T.-M, Lin, Y.-C, Shen, Y.-C
Published 2022